Aemetis Company Profile (NASDAQ:AMTX)

About Aemetis (NASDAQ:AMTX)

Aemetis logoAemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company's approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company's over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant.

Industry, Sector and Symbol:
  • Sector: Oils/Energy
  • Industry: Ethanol Fuels
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AMTX
  • CUSIP: N/A
  • Web:
  • Market Cap: $19.03 million
  • Outstanding Shares: 19,822,000
Average Prices:
  • 50 Day Moving Avg: $1.01
  • 200 Day Moving Avg: $1.22
  • 52 Week Range: $0.78 - $2.50
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $149.11 million
  • Price / Sales: 0.12
  • Book Value: ($3.23) per share
  • Price / Book: -0.28
  • EBIDTA: $400,000.00
  • Net Margins: -13.45%
  • Return on Assets: -28.36%
  • Debt-to-Equity Ratio: -1.69%
  • Current Ratio: 0.28%
  • Quick Ratio: 0.11%
  • Average Volume: 21,425 shs.
  • Beta: 0.85
  • Short Ratio: 3.98

Frequently Asked Questions for Aemetis (NASDAQ:AMTX)

What is Aemetis' stock symbol?

Aemetis trades on the NASDAQ under the ticker symbol "AMTX."

How were Aemetis' earnings last quarter?

Aemetis, Inc (NASDAQ:AMTX) posted its quarterly earnings data on Monday, November, 14th. The company reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.06. The firm earned $39.38 million during the quarter, compared to analysts' expectations of $37.75 million. View Aemetis' Earnings History.

When will Aemetis make its next earnings announcement?

Aemetis is scheduled to release their next quarterly earnings announcement on Monday, November, 13th 2017. View Earnings Estimates for Aemetis.

Where is Aemetis' stock going? Where will Aemetis' stock price be in 2017?

1 brokers have issued 12 month price objectives for Aemetis' stock. Their predictions range from $2.00 to $2.00. On average, they anticipate Aemetis' stock price to reach $2.00 in the next year. View Analyst Ratings for Aemetis.

Who are some of Aemetis' key competitors?

Who are Aemetis' key executives?

Aemetis' management team includes the folowing people:

  • Eric A. McAfee, Chairman of the Board, Chief Executive Officer
  • Todd A. Waltz, Chief Financial Officer, Executive Vice President, Secretary
  • Sanjeev Gupta, Executive Vice President and Managing Director, Chairman and President of Universal Biofuels Private, Ltd.
  • Andrew B. Foster, Chief Operating Officer, Executive Vice President
  • Lydia L. Beebe, Director
  • Francis P. Barton, Independent Director
  • John R. Block, Independent Director
  • Steven W. Hutcheson Ph.D., Independent Director
  • Harold Andrew Sorgenti, Independent Director

Who owns Aemetis stock?

Aemetis' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Geneva Advisors LLC (7.93%), Sprott Inc. (5.85%), Vanguard Group Inc. (1.21%) and Sanders Morris Harris LLC (0.56%). View Institutional Ownership Trends for Aemetis.

Who sold Aemetis stock? Who is selling Aemetis stock?

Aemetis' stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. View Insider Buying and Selling for Aemetis.

Who bought Aemetis stock? Who is buying Aemetis stock?

Aemetis' stock was bought by a variety of institutional investors in the last quarter, including Geneva Advisors LLC. View Insider Buying and Selling for Aemetis.

How do I buy Aemetis stock?

Shares of Aemetis can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aemetis' stock price today?

One share of Aemetis stock can currently be purchased for approximately $0.92.

MarketBeat Community Rating for Aemetis (NASDAQ AMTX)
Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  56 (Vote Underperform)
Total Votes:  86
MarketBeat's community ratings are surveys of what our community members think about Aemetis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Aemetis (NASDAQ:AMTX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.00 (117.39% upside)

Analysts' Ratings History for Aemetis (NASDAQ:AMTX)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/19/2017FBR & CoReiterated RatingNeutral$2.00LowView Rating Details
(Data available from 9/23/2015 forward)


Earnings History for Aemetis (NASDAQ:AMTX)
Earnings by Quarter for Aemetis (NASDAQ:AMTX)
Earnings History by Quarter for Aemetis (NASDAQ AMTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2017($0.24)N/AView Earnings Details
11/14/2016Q3 2016($0.27)($0.21)$37.75 million$39.38 millionViewN/AView Earnings Details
8/11/2016Q2($0.26)($0.25)$38.10 million$33.10 millionViewListenView Earnings Details
5/12/2016Q116($0.26)$34.70 million$33.30 millionViewListenView Earnings Details
11/5/2015Q315($0.29)$38.51 millionViewN/AView Earnings Details
3/12/2015Q4($0.18)$54.10 million$41.50 millionViewN/AView Earnings Details
11/12/2014Q3 2014$0.54$0.02$64.60 million$48.35 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aemetis (NASDAQ:AMTX)
2017 EPS Consensus Estimate: ($0.77)
2018 EPS Consensus Estimate: ($0.72)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.12)($0.12)($0.12)
Q2 20171($0.24)($0.24)($0.24)
Q3 20171($0.21)($0.21)($0.21)
Q4 20171($0.20)($0.20)($0.20)
Q1 20181($0.20)($0.20)($0.20)
Q2 20181($0.19)($0.19)($0.19)
Q3 20181($0.17)($0.17)($0.17)
Q4 20181($0.16)($0.16)($0.16)
(Data provided by Zacks Investment Research)


Dividend History for Aemetis (NASDAQ:AMTX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Aemetis (NASDAQ:AMTX)
Insider Ownership Percentage: 24.08%
Institutional Ownership Percentage: 18.71%
Insider Trades by Quarter for Aemetis (NASDAQ:AMTX)
Institutional Ownership by Quarter for Aemetis (NASDAQ:AMTX)
Insider Trades by Quarter for Aemetis (NASDAQ:AMTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Lydia I BeebeDirectorBuy10,000$1.28$12,800.00View SEC Filing  
10/4/2013Eric A McafeeCEOSell500,000$0.30$150,000.00View SEC Filing  
5/9/2013Eric A McafeeCEOSell222,222$0.45$99,999.90View SEC Filing  
12/11/2012Francis P BartonDirectorBuy50,000$0.43$21,500.00View SEC Filing  
10/24/2012Francis P BartonDirectorBuy100,000$0.58$58,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Aemetis (NASDAQ:AMTX)
Latest Headlines for Aemetis (NASDAQ:AMTX)
DateHeadline logoHow Does Aemetis Inc (AMTX) Affect Your Portfolio Returns? - September 20 at 4:18 PM logoAemetis Completes Enzymatic Biodiesel Production Unit at India Plant to Supply US and Europe - August 28 at 3:59 PM logoAemetis' (AMTX) "Neutral" Rating Reiterated at FBR & Co - August 19 at 10:20 AM logoAemetis' (AMTX) CEO Eric McAfee on Q2 2017 Results - Earnings Call Transcript - August 12 at 2:21 AM logoAemetis, Inc. Reports Second Quarter 2017 Financial Results - August 10 at 5:19 PM logoAemetis, Inc. Reports Second Quarter 2017 Financial Results - August 10 at 5:19 PM logoAemetis Producing Cellulosic Ethanol from Orchard Waste at Integrated Demonstration Unit - August 9 at 4:01 PM logoAemetis to Review Second Quarter Financial Results on August 10, 2017 - August 7 at 4:44 PM logoAemetis Signs Agreement for Advanced Gasification Technology to Produce Cellulosic Ethanol - August 4 at 4:16 PM logoAemetis, Inc (NASDAQ:AMTX) to Release Earnings on Wednesday - August 2 at 7:10 AM logoComparing REX American Resources Corporation (REX) & Aemetis (NASDAQ:AMTX) - July 27 at 11:02 AM logoREX American Resources Corporation (REX) versus Aemetis (NASDAQ:AMTX) Head to Head Review - July 25 at 8:55 AM logoAemetis (NASDAQ:AMTX) and REX American Resources Corporation (REX) Head to Head Contrast - July 24 at 8:22 PM logoFinancial Review: Aemetis (NASDAQ:AMTX) and REX American Resources Corporation (REX) - July 20 at 8:23 PM logoAemetis, Inc (NASDAQ:AMTX) Upgraded to Hold by Zacks Investment Research - July 20 at 7:45 PM logoAnalyzing REX American Resources Corporation (REX) and Aemetis (NASDAQ:AMTX) - July 20 at 10:42 AM logoZacks: Aemetis, Inc (AMTX) Receives Consensus Recommendation of "Hold" from Analysts - July 17 at 10:54 AM logoReviewing Aemetis (NASDAQ:AMTX) and Green Plains (GPRE) - July 6 at 10:20 PM logoAemetis (AMTX) & REX American Resources Corporation (REX) Critical Review - June 30 at 8:18 AM logoETFs with exposure to Aemetis, Inc. : June 14, 2017 - June 14 at 3:36 PM logoAemetis Enters into Multi-Year Biodiesel Supply Agreement with BP - May 25 at 4:08 PM logoETFs with exposure to Aemetis, Inc. : May 25, 2017 - May 25 at 4:08 PM logoAemetis Inc (AMTX) Sees Large Increase in Short Interest - May 25 at 9:40 AM logoAemetis, Inc. :AMTX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017 - May 24 at 3:30 PM logoAemetis CEO to Present at B. Riley & Co. Institutional Investor Conference on May 25th - May 23 at 3:38 PM logoFBR & Co Weighs in on Aemetis Inc's Q2 2017 Earnings (AMTX) - May 18 at 8:20 AM logoAemetis Inc (AMTX) Given a $2.00 Price Target by FBR & Co Analysts - May 17 at 7:10 PM logoAemetis Inc (AMTX) Director Buys $12,800.00 in Stock - May 16 at 4:40 PM logoAemetis Inc (AMTX) Cut to "Hold" at Zacks Investment Research - May 15 at 10:16 PM logoAemetis misses by $0.31, misses on revenue - May 11 at 3:47 PM logoAemetis, Inc. Reports First Quarter 2017 Financial Results - May 11 at 3:47 PM logoInvestor Network: AEMETIS INC to Host Earnings Call - May 11 at 3:47 PM logoAemetis Wins $6 Million Biodiesel Supply Contract with India Government Oil Companies - May 10 at 8:44 PM logoAemetis Inc (AMTX) to Release Earnings on Wednesday - May 8 at 8:32 AM logoAemetis to Review First Quarter Financial Results on May 11, 2017 - May 5 at 3:32 PM logoAemetis (AMTX) Given Daily Coverage Optimism Score of 0.25 - May 4 at 7:56 AM logoAemetis (AMTX) Receives Daily News Impact Rating of -0.12 - April 24 at 2:21 PM logoETFs with exposure to Aemetis, Inc. : April 19, 2017 - April 19 at 3:32 PM logoAmyris (AMRS) Shows Strength: Stock Adds 17.2% in Session - April 17 at 3:29 PM logoAemetis (AMTX) Given Media Sentiment Rating of 0.05 - April 17 at 11:59 AM logoETFs with exposure to Aemetis, Inc. : April 7, 2017 - April 7 at 8:34 PM logoZacks: Analysts Set $2.00 Price Target for Aemetis Inc (AMTX) - March 27 at 11:31 AM logo6:32 pm Aemetis: Edeniq filed a cross-complaint against Aemetis for fraud and negligent misrepresentation among other claims - March 24 at 1:28 AM logoAemetis Inc (AMTX) Upgraded to “Buy” by Zacks Investment Research - March 15 at 9:33 PM logoAemetis Reports Fourth Quarter and Year-End 2016 Results - March 7 at 3:32 PM logoAemetis Named to Biofuels Digest's 50 Hottest Companies 2017 - March 6 at 11:13 AM logoAemetis to Review Fourth Quarter and Year-end Financial Results on March 7, 2017 - February 28 at 9:33 AM logoAEMETIS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio - February 8 at 3:44 PM logoThe Zacks Analyst Blog Highlights: Magellan Health, WellCare Health Plans, Aemetis, NextEra Energy Partners and Oshkosh - January 12 at 3:34 PM logo6 Stocks to Gain from Obama's Economic Legacy - January 11 at 3:24 PM



Aemetis (AMTX) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by Staff